Efficacy and Safety of Oral Alendronate Treatment in Children and Adolescents with Osteoporosis

J Pediatr Endocrinol Metab. 2023 Nov 2;19(4):523-528. doi: 10.1515/jpem-2006-190410. Print 2006 Apr 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Adolescent
  • Alendronate* / administration & dosage
  • Alendronate* / adverse effects
  • Alendronate* / therapeutic use
  • Bone Density / drug effects
  • Bone Density Conservation Agents* / administration & dosage
  • Bone Density Conservation Agents* / adverse effects
  • Bone Density Conservation Agents* / therapeutic use
  • Child
  • Female
  • Humans
  • Male
  • Osteoporosis* / drug therapy
  • Treatment Outcome